Plethico Pharmaceuticals on overseas acquisition buzz

Plethico Pharmaceuticals surged 6.28% to Rs 398 at 10:49 IST on BSE on reports the company plans to acquire a US-based nutraceutical company for about $80 million to $100 million

The stock hit a high of Rs 408.40 and a low of Rs 385 so far during the day. The stock had a 52-week high of Rs 522 on 7 January 2008 and a 52-week low of Rs 295.05 on 22 January 2008.

The company has an equity capital of Rs 34.07 crore. Face value per share is Rs 10.

The current price of Rs 398 discounts its Q4 March 2008 annualised EPS of Rs 37.55, by a PE multiple of 10.60.

Plethico Pharmaceuticals’ net profit rose 24.3% to Rs 31.98 crore on 18.7% increase in net sales to Rs 128.15 crore in Q1 March 2008 over Q2 March 2007.

The company's principal activity is to manufacture and market herbal and consumer healthcare products, neutraceuticals, hospital consumables and veterinary products.